Therapeutics
Molecular Targeting
Aptamers & CpG Oligos for Targeted Therapy Development
Jump To:
Overview
Aptamers bind with high affinity and specificity to target molecules. CpG oligos act as stimulants by triggering the innate immune system.
These versatile oligonucleotides can be engineered to recognize a wide range of targets, from small molecules to proteins and even whole cells, making them a valuable tool in therapeutic applications. However, aptamer & CpG oligo synthesis requires precise control and expertise to ensure optimal binding affinity, specificity, and stability.
Oligo Factory leverages finely tuned solid phase synthetic chemistry to produce high-quality aptamers from microgram to hundreds of grams quantities. Our NANDA Series synthesizers enable precise control and enhanced purity for even the most complex aptamer & CpG sequences.

Features & Benefits
Use Cases
Facilitating Breakthroughs
Our high quality aptamers & CpG oligos are designed to support every stage of product development, from discovery to clinical application.
- Cancer immunotherapy research
- Infectious diseases
- Vaccine adjuvants
- Allergic diseases